🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

21 recruiting trials

for Resected Pancreatic Adenocarcinoma

Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX NCT07044453Phase 2, Phase 31 site📍 Rouen University Hospital, Rouen · Tests: Gem/Nabpaclitaxel infusion, mFOLFIRINOX infusion APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation NCT04858334Phase 2456 sites📍 Anchorage📍 Anchorage📍 Anchorage National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib, Placebo Administration NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101 NCT05984810Phase 21 site📍 Leiden Leiden University Medical Center · Tests: Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101 Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) NCT07252232Phase 386 sites📍 Birmingham📍 Phoenix📍 Scottsdale Revolution Medicines, Inc. · Tests: daraxonrasib Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer NCT01915225n/a1 site📍 Bethesda National Cancer Institute (NCI) Evaluation of Resection Techniques for Pancreatic Tumors NCT05128890n/a1 site📍 Dallas Methodist Health System · Tests: Resection techniques for pancreatic and liver tumors Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX NCT06349278NA1 site📍 Québec Laval University · Tests: Pancreatic resection and non-anatomic liver resections. Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy NCT04571294NA1 site📍 Rozzano Humanitas Hospital, Italy · Tests: removal of para-aortic lymphnodes (PALN) Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. NCT07148830NA1 site📍 Minya Minia University · Tests: Total Mesopancreas Excision (TMpE) (as part of Pancreaticoduodenectomy) PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer NCT05524090n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Implementation - International best-practice care Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature NCT05314998Phase 333 sites📍 Aachen📍 Augsburg📍 Bochum John Neoptolemos · Tests: Oxaliplatin, Irinotecan, Folinic acid, 5-fluorouracil, Gemcitabine The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer NCT05752812n/a1 site📍 Vienna Medical University of Vienna Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma NCT07845617n/a1 site📍 Orlando AdventHealth · Tests: Hepatic Artery Infusion Pump (HAIP), Floxuridine (FUDR) Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) NCT06384560Phase 1, Phase 24 sites📍 Amsterdam📍 Maastricht📍 Nieuwegein Amsterdam UMC, location VUmc · Tests: Pembrolizumab, Folfirinox, SABR Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer NCT04969731Phase 31 site📍 Seoul GC Cell Corporation · Tests: Immuncell-LC, Gemcitabine Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer NCT07232810NA1 site📍 Minya Minia University · Tests: Total Mesopancreas Excision (TMpE) En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria NCT06850753NA1 site📍 Oslo Oslo University Hospital · Tests: Liver transplantation after en bloc resection of the liver and pancreas Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: Genetic testing, Optional biopsy, Tissue collection Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection NCT05517811n/a2 sites📍 Aurora📍 Highlands Ranch University of Colorado, Denver · Tests: TEG indices Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma NCT06048484Phase 25 sites📍 Lake Success📍 New York📍 Chapel Hill Gulam Manji · Tests: Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat, Etrumadenant, Modified FOLFIRINOX Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma NCT07340151NA1 site📍 San Antonio The University of Texas Health Science Center at San Antonio · Tests: Surgical resection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy